Standard
The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1. / Nerild, H. H.; Bronden, A.; Haddouchi, A. E.; Holst, J. J.; Sonne, D. P.; Vilsboll, T.; Knop, F. K.
In:
Diabetologia, Vol. 64, No. SUPPL 1, 422, 2021, p. 217-217.
Research output: Contribution to journal › Conference abstract in journal › Research
Harvard
Nerild, HH
, Bronden, A, Haddouchi, AE
, Holst, JJ, Sonne, DP
, Vilsboll, T & Knop, FK 2021, '
The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1',
Diabetologia, vol. 64, no. SUPPL 1, 422, pp. 217-217.
https://doi.org/10.1007/s00125-021-05519-yAPA
Nerild, H. H.
, Bronden, A., Haddouchi, A. E.
, Holst, J. J., Sonne, D. P.
, Vilsboll, T., & Knop, F. K. (2021).
The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1.
Diabetologia,
64(SUPPL 1), 217-217. [422].
https://doi.org/10.1007/s00125-021-05519-yVancouver
Nerild HH
, Bronden A, Haddouchi AE
, Holst JJ, Sonne DP
, Vilsboll T et al.
The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1.
Diabetologia. 2021;64(SUPPL 1):217-217. 422.
https://doi.org/10.1007/s00125-021-05519-yAuthor
Nerild, H. H. ; Bronden, A. ; Haddouchi, A. E. ; Holst, J. J. ; Sonne, D. P. ; Vilsboll, T. ; Knop, F. K. / The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1. In: Diabetologia. 2021 ; Vol. 64, No. SUPPL 1. pp. 217-217.
Bibtex
@article{dfa853a57735455fb0f457213ee0f550,
title = "The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1",
author = "Nerild, {H. H.} and A. Bronden and Haddouchi, {A. E.} and Holst, {J. J.} and Sonne, {D. P.} and T. Vilsboll and Knop, {F. K.}",
year = "2021",
doi = "10.1007/s00125-021-05519-y",
language = "English",
volume = "64",
pages = "217--217",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "SUPPL 1",
}
RIS
TY - ABST
T1 - The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1
AU - Nerild, H. H.
AU - Bronden, A.
AU - Haddouchi, A. E.
AU - Holst, J. J.
AU - Sonne, D. P.
AU - Vilsboll, T.
AU - Knop, F. K.
PY - 2021
Y1 - 2021
U2 - 10.1007/s00125-021-05519-y
DO - 10.1007/s00125-021-05519-y
M3 - Conference abstract in journal
C2 - 34468792
VL - 64
SP - 217
EP - 217
JO - Diabetologia
JF - Diabetologia
SN - 0012-186X
IS - SUPPL 1
M1 - 422
ER -
